SARS has four major structural proteins, including the structural proteins including spike glycoprotein, small envelope glycoprotein, membrane glycoprotein and the nucleocapsid protein, as well as several accessory proteins. This virus can enter the body through its receptor ACE2, which is present in various organs such as heart, lungs, kidneys and gastrointestinal tract, thus facilitating entry of the virus into target cells. Through recent developments in vaccine-based therapies for cancer and other diseases, therapeutic development efforts have also focused on drug discovery that can stop the spread and replication of the virus in the host cell. To target against different coronaviruses, BOC Sciences has carefully designed a high-quality SARS coronavirus focuse library.
Figure 1. Structure of SARS-CoV2. (Vallamkondu, J.; et al. 2020)
BOC Sciences supports a 2D fingerprint similarity search method with the Tanimoto similarity cut-off (75%) to screen a reference compound set known to be active against SARS coronavirus. The target activities include:
All compounds in the reference set are selected based on acceptable maximum activity values (IC50, KI50<1000 nM, inhibition>25%). As a result, nearly 300 unique compounds are included in the reference set for subsequent similarity searches
BOC Sciences provides professional, rapid and high-quality services of SARS Coronavirus Focuse Library design at competitive prices for global customers. Personalized and customized services of SARS Coronavirus Focuse Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.